4.7 Article

Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naive major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks

期刊

JOURNAL OF AFFECTIVE DISORDERS
卷 136, 期 3, 页码 453-458

出版社

ELSEVIER
DOI: 10.1016/j.jad.2011.11.004

关键词

Duloxetine; Regional homogeneity; Major depressive disorder; Panic disorder

资金

  1. Buddhist Tzu Chi General Hospital, Taipei Branch [TCRD-TPE-97-02]

向作者/读者索取更多资源

Objective: We designed this study to investigate the changes of regional homogeneity (ReHo) after a 6-week duloxetine therapy in first-episode drug-naive major depressive disorder with panic disorder (FEMDDPD) patients. Method: 31 magnetic resonance imaging (MRI) scanning and ReHo functional MRI analysis were performed on 15 patients (male: 5; female: 10; age: 35.87 +/- 9.59 years old) at baseline and remitted status (sixth week) compared with 15 healthy control subjects (male: 4: female: 11; age: 34.30 +/- 9.87 years old) which were scanned twice within 6 weeks. The ReHo was analyzed by the REST toolbox (resting-state functional MRI data analysis toolbox). The ReHos of different time-points were compared by using paired t test function of REST. Results: ReHo increased in right superior frontal cortex, right medial frontal cortex and decreased in right superior temporal cortex (uncorrected p<0.00005, cluster threshold >20, surface connected theory) after remission of symptoms in these FEMDDPD patients within 6 weeks (improvements of clinician rating and self rating scale scores; post-hoc corrected p<0.001). No significant changes of ReHo were observed in the controls within 6 weeks (uncorrected p<0.1, no cluster threshold setting, surface connected theory). The changes of ReHo value were mildly correlated with improvements of clinical rating scales with age, gender, depression and anxiety severity as covariates. Conclusion: Our study suggested that differential modulations inside the default mode network probably were associated with remission of FEMDDPD symptoms after duloxetine therapy. (C) 2011 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据